Trial intelligence / Profile preview

Theraworx vs CHG Wipes for Surgical Site Infection Prophylaxis in Orthopaedic Surgery

NCT03401749Phase 4Terminated

Sponsor
University of Alabama at Birmingham
Start
Nov 2018
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Theraworx in surgical site infection (SSI), sponsored by University of Alabama at Birmingham. Started Nov 2018; status: terminated.

02

Drugs

Theraworx
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT03401749.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03401749.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call